Executive record
Azita Saleki-Gerhardt
Public governance roles and source-backed Claims for this individual.
More
Alpha ID: alpha:person:azita-saleki-gerhardtVersion: public-0As of: 2026-10-04
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
Biography
Dr. Saleki-Gerhardt has served as Executive Vice President and Chief Operations Officer at AbbVie since July 2023, overseeing domestic and international manufacturing, quality and distribution networks. She spent more than twenty years at Abbott Laboratories in senior management roles focused on operations, manufacturing and quality before AbbVie's spin-off in 2013.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Claims
Executive career
- Dates not publishedExecutive title: Executive Vice President, Chief Operations Officer · Organization not publishedENTG DEF 14A director slate
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
1 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
ENTG DEF 14A director slate
sec filing · Source published: Mar 23, 2026 · Retrieved: May 7, 2026
Supports 7 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 7, 2026
- Board role: Board role: Director · Claim reviewed: May 7, 2026
- Committee assignments: Committee assignments: Nominating/Governance, ESG · Claim reviewed: May 7, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 7, 2026
- Executive company: Executive at AbbVie Inc. · Claim reviewed: May 7, 2026
- Executive title: Executive title: Executive Vice President, Chief Operations Officer · Claim reviewed: May 7, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 7, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-04
- Biography
- published
- Board service
- published
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope